Edap Tms (NASDAQ:EDAP) Stock Rating Lowered by StockNews.com

Edap Tms (NASDAQ:EDAP) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell” rating in a report released on Friday.

Separately, HC Wainwright lifted their target price on Edap Tms from $16.00 to $19.00 and gave the company a “buy” rating in a research report on Monday, April 1st.

Edap Tms Stock Down 3.1 %

Shares of NASDAQ:EDAP opened at $7.13 on Friday. Edap Tms has a 12-month low of $3.60 and a 12-month high of $12.23. The company has a market capitalization of $264.52 million, a price-to-earnings ratio of -11.32 and a beta of 0.74. The business has a 50-day moving average price of $7.09 and a 200 day moving average price of $6.26. The company has a current ratio of 2.84, a quick ratio of 2.30 and a debt-to-equity ratio of 0.04.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. Cetera Advisor Networks LLC raised its position in shares of Edap Tms by 0.9% during the 4th quarter. Cetera Advisor Networks LLC now owns 111,162 shares of the medical equipment provider’s stock worth $1,185,000 after acquiring an additional 944 shares in the last quarter. BlackRock Inc. raised its stake in shares of Edap Tms by 27.3% during the 1st quarter. BlackRock Inc. now owns 13,527 shares of the medical equipment provider’s stock worth $150,000 after buying an additional 2,898 shares in the last quarter. Envestnet Asset Management Inc. raised its position in Edap Tms by 24.6% in the third quarter. Envestnet Asset Management Inc. now owns 14,736 shares of the medical equipment provider’s stock worth $122,000 after acquiring an additional 2,911 shares in the last quarter. Commonwealth Equity Services LLC increased its holdings in shares of Edap Tms by 5.3% in the 1st quarter. Commonwealth Equity Services LLC now owns 65,135 shares of the medical equipment provider’s stock valued at $721,000 after purchasing an additional 3,250 shares in the last quarter. Finally, Royal Bank of Canada increased its holdings in Edap Tms by 22.5% in the second quarter. Royal Bank of Canada now owns 18,375 shares of the medical equipment provider’s stock valued at $169,000 after buying an additional 3,375 shares in the last quarter. Hedge funds and other institutional investors own 62.74% of the company’s stock.

Edap Tms Company Profile

EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.